Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.995    -0.215 (-9.73%)
Bid:
1.905
Ask:
2.19
Spread: 0.285 (14.961%)
Market Cap: £40.02m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Successful Sparkle Power Programme Testing

17 Sep 2025 07:00

RNS Number : 5968Z
Quadrise PLC
17 September 2025
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

17 September 2025

 

Quadrise plc

("Quadrise", "QED" or the "Company")

 

Successful completion of Sparkle Power testing programme

 

Quadrise plc (AIM: QED), the technology company focused on the decarbonisation of shipping and heavy industry through deployment of low emission fuels and biofuels, is pleased to announce the successful completion of proof-of-concept and emissions testing programmes for its MSAR® and bioMSAR™ fuels at the Sparkle Power SA ("Sparkle") plant in El Giral, Panama.

 

These trials mark the first successful application of MSAR® and bioMSAR™ on Everllence (formerly MAN Energy Solutions) 4-stroke engines, expanding the commercial potential of these fuels across additional engine types in energy-intensive sectors seeking cost-effective decarbonisation solutions.

 

Testing on MSAR® and bioMSAR™ fuels was conducted over a 24 hour period on an Everllence 18V32/40 8MW engine. A subsequent shorter run was completed on a Everllence 9L28/32 4MW engine. The trials were conducted by experts from Quadrise and Sparkle, and supported by independent specialists in external engine performance, emissions and fuel testing.

 

The key success criteria of the main trial were met as follows:

 

· Engine efficiency was improved, consistent with results on Wärtsilä diesel engines.

· NOx emissions were reduced by 25% with bioMSAR and 32% with MSAR®.

· Particulate matter emissions were reduced by 20% using both fuels.

 

The Sparkle trials validated the expected performance of MSAR® and bioMSAR™ for commercial deployment and confirmed the fuel injection system modifications required to achieve maximum load. The parties are now jointly planning the next steps towards confirming commercial supply arrangements for Sparkle and fuel permitting in Panama.

Jason Miles, Chief Technology Officer of Quadrise, commented:

"The successful trials with Sparkle represent a significant milestone for Quadrise, demonstrating the viability of MSAR® and bioMSAR™ on Everllence 4-stroke engines through a strong collaborative endeavour. With confirmed improvements in engine efficiency and emissions, we look forward to advancing discussions with Sparkle and a regional supply partner to establish a commercial supply facility serving the power and marine sectors across Central America."

Jose Castillo, General Manager of Sparkle, commented:

 

"We are delighted to have completed the Everllence engine test of MSAR® and bioMSAR™ at our power plant. The Quadrise test has confirmed the fuels are viable replacements for heavy fuel oil at our facility.

Sparkle Power is committed to becoming more fuel efficient and conserving the environment by reducing emissions in accordance with the government's policies for environmental conservation in Panama. The test has confirmed that MSAR® and bioMSAR™ fuels can achieve the necessary criteria for commercial implementation in the country."

 

For further information please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Technology Officer

 

 

Nominated Adviser

Cavendish Capital Markets Limited

 

 

+44 (0)20 7220 0500

Ben Jeynes

Katy Birkin

George Lawson

 

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Harry Davies-Ball (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

 

 

+44 (0)20 3005 5000

 

Public & Investor Relations

 

 

Tavistock Communications (Financial PR & IR)

Simon Hudson

Nick Elwes

Ruairi Millar

 

+44 (0) 20 7920 3150

 

 BLUE Communications Limited (Marine & Trade PR)

 Rhys Thomas

 Sam Deacon

 

 

 

+44 (0)7595 227750

+44 (0)7527 558846

 

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to lower energy costs, pollution and greenhouse gas emissions today for the global power generation, shipping, industrial and oil industries.

Learn more at: www.quadrise.com

 

Follow us on social media:

LinkedIn: @Quadrise Plc

X: @QuadrisePlc

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFFTASIRLIE
Date   Source Headline
26th Nov 200912:59 pmBUSDisclosure of Short Position
24th Nov 200911:25 amRNSResult of General Meeting
18th Nov 20095:15 pmRNSHolding(s) in Company
16th Nov 20095:24 pmRNSHolding(s) in Company
10th Nov 20099:49 amRNSHolding(s) in Company
6th Nov 20093:05 pmRNSDirector/PDMR Shareholding
6th Nov 20093:01 pmRNSHolding(s) in Company
6th Nov 20092:20 pmBUSDisclosure of Short Position
5th Nov 200912:56 pmRNSPublication of Prospectus
5th Nov 20097:00 amRNSRights Issue
5th Nov 20097:00 amRNSHalf Yearly Results
4th Nov 20096:28 pmRNSHolding(s) in Company
3rd Nov 20095:48 pmRNSHolding(s) in Company
2nd Nov 20097:00 amRNSStatement re. Press Comment
13th Oct 20092:55 pmRNSDirector/PDMR Shareholding
12th Oct 20092:18 pmRNSHolding(s) in Company
9th Oct 20097:00 amRNSDisposal
1st Oct 20097:00 amRNSTrading Statement
30th Sep 200911:08 amRNSTotal Voting Rights
29th Sep 20091:20 pmRNSHolding(s) in Company
16th Sep 20092:18 pmRNSDirector/PDMR Shareholding
15th Sep 200910:12 amRNSHolding(s) in Company
11th Sep 20094:57 pmRNSHolding(s) in Company
11th Sep 20093:56 pmRNSHolding(s) in Company
11th Sep 20097:00 amRNSDisposal
9th Sep 20093:30 pmRNSResult of AGM
9th Sep 20099:45 amRNSDirectorate Change
2nd Sep 200912:42 pmRNSHolding(s) in Company
1st Sep 20093:31 pmRNSHolding(s) in Company
1st Sep 200912:01 pmRNSHolding(s) in Company
26th Aug 20093:48 pmRNSHolding(s) in Company
24th Aug 20095:09 pmRNSHolding(s) in Company
21st Aug 20093:37 pmRNSHolding(s) in Company
19th Aug 200911:52 amRNSDirector/PDMR Shareholding
18th Aug 200911:04 amRNSDirector/PDMR Shareholding
14th Aug 200911:00 amRNSAnnual Information Update
14th Aug 20099:43 amRNSHolding(s) in Company
13th Aug 20099:37 amRNSDirector/PDMR Shareholding
11th Aug 20099:14 amRNSDirector/PDMR Shareholding
7th Aug 200912:10 pmRNSDirector/PDMR Shareholding
31st Jul 200912:51 pmRNSTotal Voting Rights
29th Jul 20097:00 amRNSInterim Management Statement
28th Jul 20093:18 pmRNSNotice of IMS
16th Jul 20092:33 pmRNSDirector/PDMR Shareholding
16th Jul 200912:19 pmRNSDirector Declaration
15th Jul 20097:00 amRNSDirector/PDMR Shareholding
13th Jul 20092:45 pmRNSAnnual Financial Report
7th Jul 20092:20 pmRNSHolding(s) in Company
25th Jun 20095:17 pmRNSNotification of major interest in shares
22nd Jun 200912:54 pmRNSInterests of Directors and PDMRs

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.